Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review

Pharmacoeconomics. 2019 Dec;37(12):1553. doi: 10.1007/s40273-019-00833-1.

Abstract

CORE diabetes model was used throughout the article for consistency.

Publication types

  • Published Erratum